Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra

[1]  A. C. Belin,et al.  Parkinson’s disease: A genetic perspective , 2008, The FEBS journal.

[2]  T. Dawson,et al.  Dynamic and redundant regulation of LRRK2 and LRRK1 expression , 2007, BMC Neuroscience.

[3]  David I. Bass,et al.  A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease , 2007, Neuroscience.

[4]  P. Emson,et al.  Localization of Parkinson’s disease-associated LRRK2 in normal and pathological human brain , 2007, Brain Research.

[5]  P. Barone,et al.  Apoptotic mechanisms in mutant LRRK2-mediated cell death. , 2007, Human molecular genetics.

[6]  N. Hattori,et al.  Leucine-rich repeat kinase 2 associates with lipid rafts. , 2007, Human molecular genetics.

[7]  K. Lim,et al.  Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. , 2007, Human molecular genetics.

[8]  M. Farrer,et al.  Anatomical localization of leucine-rich repeat kinase 2 in mouse brain , 2006, Neuroscience.

[9]  J. Jankovic,et al.  Genetic testing in Parkinson disease: promises and pitfalls. , 2006, Archives of neurology.

[10]  David W. Miller,et al.  Kinase activity is required for the toxic effects of mutant LRRK2/dardarin , 2006, Neurobiology of Disease.

[11]  V. Baekelandt,et al.  Distribution of PINK1 and LRRK2 in rat and mouse brain , 2006, Journal of neurochemistry.

[12]  O. Sydow,et al.  LRRK2 expression linked to dopamine‐innervated areas , 2006, Annals of neurology.

[13]  J. Simón‐Sánchez,et al.  LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain , 2006, The European journal of neuroscience.

[14]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[15]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[16]  Lorraine Iacovitti,et al.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture , 2005, Molecular and Cellular Neuroscience.

[17]  A. Singleton.  Altered α-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin , 2005, Trends in Neurosciences.

[18]  C. Summerfield,et al.  Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. , 2005, Archives of neurology.

[19]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[20]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[21]  K. Gollomp,et al.  The human tyrosine hydroxylase gene promoter. , 2003, Brain research. Molecular brain research.

[22]  A. Singleton.  Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin. , 2005, Trends in neurosciences.

[23]  J. Ghika.  [Genetics of parkinsonism]. , 2000, Revue medicale de la Suisse romande.